Millipore Sigma Vibrant Logo
 

trial++size


221 Results Advanced Search  
Showing

Narrow Your Results Use the filters below to refine your search

By Application

  • (2)

By Industry

  • (2)
Can't Find What You're Looking For?
Contact Customer Service

 
  • Phase III | Emerging Biotech | Merck

    Phase III trials use a much larger patient population - in the thousands - to give statistical weight to results that can prove safety and efficacy.
  • Histones and Histone Modifications | Life Science Research | Merck

    Histone modifications regulate DNA transcription, repair, recombination, and replication, and can alter local chromatin architecture. Understanding histone modifications is key to uncovering epigenetic mechanisms of gene regulation. Merck grasps the complexity of this research and provides a growing line of kits, antibodies, and assays for studying histones and their modifications. Merck offers over 600 validated antibodies, recombinant proteins, and kits to analyze histone and histone-variant phosphorylation, methylation, acetylation, ubiquitination, and citrullination-the most widely studied histone modifications in epigenetics today.
  • Case Studies | Merck

    Our global network of regulatory expertise and services, combined with blood plasma fractionation quality systems, provide a flexible and customized solution for you. We will never give up and will power through every challenge that faces you.